Fundraising FoxAtlyphe
1 known investors
Find your way into Atlyphe
Each arrow is one introduction. Sign up to fill in the first one.
178 people can intro you to Maddalena
Ask Nicolas Muntwyler to introduce you to Maddalena Marconato
You →Nicolas · together at Universitätsspital Zürich →Maddalena
Sign up to find every way you can get introduced to Atlyphe
- Your email: who you already know at Atlyphe, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Atlyphe team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Zürich biotech developing targeted immunotherapy (ALY117) for stem cell transplantation and cancer.
Founders & leadership
MM
Maddalena MarconatoFounderMarconato is a physician-scientist with board certifications in clinical immunology and hematology who has led translational research projects in novel immunotherapies and early-phase clinical trials. She founded Atlyphe, a Zürich-based biotech company developing targeted immunotherapy for stem cell transplantation and cancer.
Investors · 1
Kickfundlisted by KickfundBasel · $950K
How we know: Kickfund's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Atlyphe do?
- Zürich biotech developing targeted immunotherapy (ALY117) for stem cell transplantation and cancer.
- Who founded Atlyphe?
- Atlyphe was founded by Maddalena Marconato.
- Who are Atlyphe's investors?
- Atlyphe's investors include Kickfund.